1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Diabetes App Market Report 2014

Diabetes App Market Report 2014

  • January 2014
  • -
  • Research2guidance
  • -
  • 113 pages

The Diabetes App Market Report 2014 is a comprehensive analysis about the performance of diabetes apps, key players, best practices, country markets, regulatory impact, market trends and revenues from 2008 - 2018.
Diabetes has become a global epidemic with significant impact on society and the economy. In 2013 around 382M people around the world were estimated to suffer from diabetes. Mobile applications promise to play an invaluable role in assisting people who suffer from diabetes to empower them to better manage their condition and as a consequence reduce health care costs. Mobile apps can aid in the daily management of diabetes by supporting behaviour changes, facilitating communication and easing the hassle of keeping track of all relevant parameters that have an influence on the disease.
Currently there are more than 1.100 iOS and Android apps listed on the Apple App Store and Google Play that are specifically designed for diabetics and healthcare professionals to treat diabetics.
The report examines in detail the initial years of the app market (2008-2013) and provides an outlook of the next phase (2014-2018).

The report includes:

- Analysis and categorization of 1.100 diabetes apps
- Description of 6 best practice elements that constitutes a successful diabetes app
- Detailed market analysis of the last 5 years (2008-2013) including size of the addressable market, downloads, business model and platform market share, app and in-app-purchase price development, market revenue total and by revenue sources
- Profiles of top 14 diabetes app publishers that represent 65% of market share including diabetes app portfolio description and its performance
- Top 10 country profiles that represent the biggest local markets for diabetes apps including cumulated market downloads and active users per platform
- Analysis of available clinical trials that investigate the impact of mobile apps on the diabetes care
- Interpretation of regulatory guidelines from the FDA on diabetes apps
- Description of the main factors that will influence the diabetes app market in the next five years
- Detailed market forecast including downloads, revenues, user penetration in target group, app related sensor shipment and service user numbers

The report answers questions like:

- What is the addressable market of diabetes apps globally and in major countries?
- What constitutes a best practice diabetes app?
- Under which circumstances does a diabetes app have to get pre-market approval by the regulatory organizations?
- What are the main competitors and how do they perform?
- What size has the addressable market in one of the major countries?
- What are the main sources of revenue for diabetes app publishers today and in five years?

The report is based on a detailed data set of 1.100 diabetes apps available for the iOS and Android operating system in 27 countries.
More than 30 interviews with physicians, diabetics, app developers and publishers have been conducted to discuss the current status of the market as well as future trends.
In addition, more than 20 mHealth app communities have been investigated to include feedback from diabetes app users. The most representative feedback from the interviews and community investigation are included in the report.

Table Of Contents

Diabetes App Market Report 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects Summary Type 2 diabetes ...

Diabetes Injection Pens Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024

Diabetes Injection Pens Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Global Diabetes Injection Pens Market: Overview This report on diabetes injection pens market studies the current as well as future prospects of the market globally. The stakeholders of this report include ...

Global Diabetes Diagnostics Industry

Global Diabetes Diagnostics Industry

  • $ 4950
  • Industry report
  • October 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Diabetes Diagnostics in US$ Thousand by the following Product Segments: Continuous Glucose Monitoring (CGM) Systems, HbA1c Testing Devices, and Blood Glucose ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.